Loading…
Fox Pharma LLC was warned for selling unapproved injectable lipolytic products including LemonBottle Ampoule Solution, Lipo Lab PPC Solution, Lipo Vela, Lipo Lab V-Line, Kabelline, and Super V-Line Sol through its website and social media platforms in violation of sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act. The company marketed these products with drug claims such as promoting "fat decomposition to increase metabolism of fat cells," establishing them as unapproved new drugs lacking required FDA approval. The FDA emphasized the heightened public health risk posed by injectable products, which bypass the body's natural defenses against toxins and microorganisms and can cause serious or life-threatening conditions.